HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotherapy in gram-negative bacterial infections.

Abstract
Endotoxins are responsible for initiation of septic shock which increases the number of fatalities in Gram-negative bacteremia among hospital patients. The mortality from septic shock is still high despite recent developments in antibiotic therapy because antibiotics are unable to decrease the level of free lipopolysaccharide in the blood stream. Another approach to the treatment and prevention of septicaemia involves stimulation of an immune response against LPS. It was found that immunization with the core structures of endotoxin conjugated with proteins protected animals against infections and endotoxic shock. Anticonjugate sera are of great interest because they are directed against conserved parts of LPS and therefore could have cross-reactive and cross-protective properties with respect to many Gram-negative rods.
AuthorsC Lugowski
JournalActa biochimica Polonica (Acta Biochim Pol) Vol. 42 Issue 1 Pg. 19-24 ( 1995) ISSN: 0001-527X [Print] Poland
PMID7653155 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, Bacterial
  • Lipopolysaccharides
  • Tetanus Toxoid
  • enterobacterial common antigen
Topics
  • Animals
  • Antigens, Bacterial (chemistry, immunology)
  • Carbohydrate Sequence
  • Enterobacteriaceae (immunology)
  • Gram-Negative Bacterial Infections (complications)
  • Humans
  • Immunization, Passive
  • Lipopolysaccharides (adverse effects, chemistry, immunology)
  • Macrophage Activation
  • Mice
  • Molecular Sequence Data
  • Rabbits
  • Shock, Septic (etiology, prevention & control)
  • Tetanus Toxoid (immunology)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: